Cebix's Series A - II Round

Cebix raised a round of funding on August 09, 2010.

Cebix is developing Ersatta, a disease-modifying replacement peptide for the treatment of complications associated with diabetes. Ersatta is a long-acting form of C-peptide that, unlike other products…

Articles about Cebix's Series A - II Round: